Cipla Limited Share Price

Equities

CIPLA

INE059A01026

Pharmaceuticals

Market Closed - NSE India S.E. 12:40:29 29/05/2024 BST 5-day change 1st Jan Change
1,494 INR +0.95% Intraday chart for Cipla Limited +0.76% +19.84%

Financials

Sales 2024 258B 3.09B 243B Sales 2025 * 280B 3.37B 264B Capitalization 1,195B 14.34B 1,126B
Net income 2024 41.22B 495M 38.84B Net income 2025 * 46.6B 559M 43.92B EV / Sales 2024 4.69 x
Net cash position 2024 * 55.83B 670M 52.61B Net cash position 2025 * 57.78B 693M 54.46B EV / Sales 2025 * 4.05 x
P/E ratio 2024
29.3 x
P/E ratio 2025 *
25.7 x
Employees 32,323
Yield 2024 *
0.57%
Yield 2025 *
0.67%
Free-Float 67.03%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.95%
1 week+0.76%
Current month+6.68%
1 month+6.08%
3 months+0.89%
6 months+24.30%
Current year+19.84%
More quotes
1 week
1 462.70
Extreme 1462.7
1 504.55
1 month
1 317.25
Extreme 1317.25
1 504.55
Current year
1 252.10
Extreme 1252.1
1 519.00
1 year
942.30
Extreme 942.3
1 519.00
3 years
850.00
Extreme 850
1 519.00
5 years
355.30
Extreme 355.3
1 519.00
10 years
355.30
Extreme 355.3
1 519.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 30/09/15
Director of Finance/CFO - 15/08/22
Chief Tech/Sci/R&D Officer - 31/12/85
Members of the board TitleAgeSince
Director/Board Member 72 15/07/13
Chairman 87 21/07/72
Director/Board Member 83 15/08/77
More insiders
Date Price Change Volume
29/05/24 1,494 +0.95% 1 607 691
28/05/24 1,479 +0.05% 784,496
27/05/24 1,479 -0.52% 1,393,334
24/05/24 1,486 -0.18% 758,326
23/05/24 1,489 +0.46% 4,389,470

Delayed Quote NSE India S.E., May 29, 2024 at 12:40 pm

More quotes
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
1,479 INR
Average target price
1,476 INR
Spread / Average Target
-0.21%
Consensus